248 related articles for article (PubMed ID: 17343295)
1. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
[TBL] [Abstract][Full Text] [Related]
2. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
[TBL] [Abstract][Full Text] [Related]
3. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
[TBL] [Abstract][Full Text] [Related]
5. Normal development and function of dendritic cells in mice lacking IDO-1 expression.
de Faudeur G; de Trez C; Muraille E; Leo O
Immunol Lett; 2008 Jun; 118(1):21-9. PubMed ID: 18384884
[TBL] [Abstract][Full Text] [Related]
6. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
[TBL] [Abstract][Full Text] [Related]
7. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
Puccetti P; Fallarino F
Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
[TBL] [Abstract][Full Text] [Related]
8. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
[TBL] [Abstract][Full Text] [Related]
9. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion.
Miwa N; Hayakawa S; Miyazaki S; Myojo S; Sasaki Y; Sakai M; Takikawa O; Saito S
Mol Hum Reprod; 2005 Dec; 11(12):865-70. PubMed ID: 16421220
[TBL] [Abstract][Full Text] [Related]
10. Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells.
Lee HJ; Jeong YI; Lee TH; Jung ID; Lee JS; Lee CM; Kim JI; Joo H; Lee JD; Park YM
Biochem Pharmacol; 2007 May; 73(9):1412-21. PubMed ID: 17229401
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
Mellor AL; Baban B; Chandler PR; Manlapat A; Kahler DJ; Munn DH
J Immunol; 2005 Nov; 175(9):5601-5. PubMed ID: 16237046
[TBL] [Abstract][Full Text] [Related]
12. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
López AS; Alegre E; LeMaoult J; Carosella E; González A
Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
[TBL] [Abstract][Full Text] [Related]
13. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
14. On watching the watchers: IDO and type I/II IFN.
Puccetti P
Eur J Immunol; 2007 Apr; 37(4):876-9. PubMed ID: 17393386
[TBL] [Abstract][Full Text] [Related]
15. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
16. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.
Fallarino F; Orabona C; Vacca C; Bianchi R; Gizzi S; Asselin-Paturel C; Fioretti MC; Trinchieri G; Grohmann U; Puccetti P
Int Immunol; 2005 Nov; 17(11):1429-38. PubMed ID: 16172135
[TBL] [Abstract][Full Text] [Related]
17. Marked increases in hippocampal neuron indoleamine 2, 3-dioxygenase via IFN-gamma-independent pathway following transient global ischemia in mouse.
Hoshi M; Saito K; Murakami Y; Taguchi A; Fujigaki H; Tanaka R; Takemura M; Ito H; Hara A; Seishima M
Neurosci Res; 2009 Mar; 63(3):194-8. PubMed ID: 19121343
[TBL] [Abstract][Full Text] [Related]
18. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
[TBL] [Abstract][Full Text] [Related]
19. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma.
Maneechotesuwan K; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Yaikwawong M; Barnes PJ; Wongkajornsilp A
J Allergy Clin Immunol; 2009 Jan; 123(1):239-48. PubMed ID: 19058839
[TBL] [Abstract][Full Text] [Related]
20. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
